Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?
Zachary A Marcum, Jordana B Cohen, Eric B Larson, Jeff Williamson, Adam P Bress
{"title":"Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?","authors":"Zachary A Marcum, Jordana B Cohen, Eric B Larson, Jeff Williamson, Adam P Bress","doi":"10.31478/202205c","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74236,"journal":{"name":"NAM perspectives","volume":"2022 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499377/pdf/nampsp-2022-202205c.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAM perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31478/202205c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}